Sign In
Buy ADVM
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
10:36am, Wednesday, 27'th Mar 2024
The heavy selling pressure might have exhausted for Adverum Biotechnologies (ADVM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall St
Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
10:46am, Tuesday, 19'th Mar 2024
Here is how Adverum Biotechnologies (ADVM) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
- Preliminary LUNA data presented at the Annual Meeting of the Macula Society support potential best-in-class clinical activity and an encouraging safety profile in patients with wet AMD -
Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
03:07pm, Wednesday, 06'th Mar 2024
There are plenty of penny stocks ready to pop. However, we have to remember that penny stocks are extremely risky, and can be costly in the end.
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
04:05pm, Wednesday, 28'th Feb 2024
REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly p
Stocks on the Launchpad: The Next 3 Market Sensations
06:10am, Tuesday, 27'th Feb 2024
In the current bullish stock market, it's an exhilarating period for savvy investors betting on the upcoming market sensations. The optimism is connected to the S&P 500 shattering the historic 5000 th
Unleash Massive Returns With These 3 Top Penny Stocks
06:15am, Thursday, 22'nd Feb 2024
Despite a recent decline in the leading economic index, the U.S. economy is positioned for a positive future in 2024. Strong employment and robust stock levels contribute to the optimistic outlook.
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
08:00am, Monday, 12'th Feb 2024
REDWOOD CITY, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and maintenance of both visual acuity and anatom
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
07:45am, Monday, 05'th Feb 2024
- Financing led by TCGX with participation from new and existing investors including 5AM Ventures, Commodore Capital, Frazier Life Sciences, Logos Capital, Samsara BioCapital, Venrock Healthcare Capit
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024
05:30pm, Thursday, 01'st Feb 2024
- Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47 th Annual Meeting of the Macula Society, with company-sponsor
Here's Why You Should Invest in Adverum (ADVM) Stock Now
09:47am, Thursday, 04'th Jan 2024
Here, we discuss some reasons why buying Adverum Biotechnologies (AQST) stock now may turn out to be a prudent move.
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society
04:05pm, Thursday, 07'th Dec 2023
REDWOOD CITY, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly
Adverum Biotechnologies to Participate in Upcoming Investor Conferences
04:05pm, Thursday, 21'st Sep 2023
REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly
Adverum Biotechnologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
04:05pm, Tuesday, 05'th Sep 2023
REDWOOD CITY, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly
